Products
Online Inquiry
Galeterone
Cat. No.:
OB0225WX-2520
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Galeterone is a dual-function molecule that acts as both a selective CYP17 inhibitor (IC50: 300 nM) and an androgen receptor (AR) antagonist (IC50: 384 nM).
Synonym:
TOK-001; 851983-85-2; VN/124-1; Galaterone; TOK 001; (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene; 17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3beta-ol; (3S,8R,9S,10R,13S,14S)-17-(1H-Benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; Androsta-5,16-dien-3-ol, 17-(1H-benzimidazol-1-yl)-, (3beta)-; (3beta)-17-(1h-benzimidazol-1-yl)androsta-5,16-dien-3-ol; (1S,2R,5S,10R,11S,15S)-14-(1H-1,3-benzodiazol-1-yl)-2,15-dimethyltetracyclo(8.7.0.02,?.011,1?)heptadeca-7,13-dien-5-ol; (1S,2R,5S,10R,11S,15S)-14-(1H-1,3-benzodiazol-1-yl)-2,15-dimethyltetracyclo[8.7.0.02,?.011,1?]heptadeca-7,13-dien-5-ol; (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta(a)phenanthren-3-ol; MFCD16660907
CAS No.:
851983-85-2
Compound CID:
11188409
Formula:
C26H32N2
Formula Weight:
388.55
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Galeterone is employed in endocrine oncology research as a multi-target agent to investigate the inhibition of CYP17, androgen receptor antagonism, and the induction of androgen receptor degradation.
Library Information
Target:
Androgen receptor; P450
Receptor:
Androgen receptor; CYP17
Pathways:
Endocrinology & Hormones
Plate Number:
L6700-04
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
24 mg/mL; 61.77 mM
Ethanol Max Solubility:
40 mg/mL
ALogP:
4.897
HBA_Count:
1
HBD_Count:
1
Rotatable Bond:
1





